CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 1,809 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,809 | +0.5% | 0.00% | – |
| Q4 2016 | $1,000 | -66.7% | 1,800 | -45.5% | 0.00% | – |
| Q3 2016 | $3,000 | -72.7% | 3,300 | -37.7% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 5,300 | +10.4% | 0.00% | – |
| Q1 2016 | $13,000 | 0.0% | 4,800 | 0.0% | 0.00% | – |
| Q4 2015 | $13,000 | -27.8% | 4,800 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -18.2% | 4,800 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | -15.4% | 4,800 | +68.4% | 0.00% | – |
| Q1 2015 | $26,000 | +333.3% | 2,850 | +185.0% | 0.00% | – |
| Q4 2014 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |